Generics: Global Industry Guide

Generics: Global Industry Guide
  • Report price : $ 1 495
  • Publication date : October 2009

Get this report now!

Generics: Global Industry Guide

The Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the Generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).

* Includes a five-year forecast of the industry

Highlights

The global generics market grew by 3.1% in 2008 to reach a value of $191.8 billion.

In 2013, the global generics market is forecast to have a value of $292 billion, an increase of 52.2% since 2008.

Sales of ethical drugs proved the most lucrative for the global generics market in 2008, generating 80.9% of the market’s overall revenue.

Americas leads the global generics market accounting for 59.7% of the market's revenue.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. The defines a generic as an officially-approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name.

This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. Multi-source copies are drugs still under patent that are offered by manufacturers other than the patent holders.

RELATED REPORTS

Analgesics in Romania

Analgesics in Romania

  • $ 898
  • September 2009

Euromonitor International's Analgesics in Romania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading ...

Industries : Generic Drug

Analgesics in Mexico

Analgesics in Mexico

  • $ 898
  • September 2009

Euromonitor International's Analgesics in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading ...

Industries : Generic Drug

Analgesics in Venezuela

Analgesics in Venezuela

  • $ 898
  • August 2009

Euromonitor International's Analgesics in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading ...

Industries : Generic Drug

Analgesics in Slovakia

Analgesics in Slovakia

  • $ 898
  • July 2009

Euromonitor International's Analgesics in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading ...

Industries : Generic Drug

Analgesics in Morocco

Analgesics in Morocco

  • $ 898
  • August 2009

Euromonitor International's Analgesics in Morocco report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading ...

Industries : Generic Drug

US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts

US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts

  • $ 1 125
  • July 2005

The US generics market was estimated at US$18.1 billion in 2004; the leading European generics markets together totalled between US$10-US$11 billion for the same period. This new report asks why there is such a difference in value? Contrasts in regulatory systems, legislative background and market ...

Industries : Generic Drug

Biogenerics: Challenges and Promise

Biogenerics: Challenges and Promise

  • $ 999
  • January 2005

This brand new report published in November 2004 takes an insightful look at the burgeoning biogenerics industry.This report primarily focuses on how the generics industry will be shaped by the global healthcare market and regulatory developments over the next five years. The international biogen ...

Industries : Generic Drug

Antibiotics - Global Trends

Antibiotics - Global Trends

  • $ 2 995
  • November 2009

Long-term growth in the global antibiotics market would be affected by two major factors - antibiotic resistance and generic competition. Antibiotic resistance, which compels reduction in the usage of antibiotics, represents the primary market inhibitor. In recent times, there has been a decline in ...

Industries : Pharmaceutical, Generic Drug

24/7 Customer Service

Contact Clare now !

Related industries

Related companies

reportlinker.com © Copyright 2010. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.